Premium
Angioedema, lymphoproliferative disorder and angiotensin‐converting enzyme inhibitors: masking of diagnosis by corticosteroids
Author(s) -
Hissaria P.,
Lim S.W.,
Hui C.H.,
Gillis D.,
Kette F.,
Smith W.
Publication year - 2007
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/j.1445-5994.2007.01459.x
Subject(s) - angioedema , medicine , angiotensin converting enzyme , dermatology , lymphoproliferative disorders , c1 inhibitor , ace inhibitor , hereditary angioedema , immunology , lymphoma , blood pressure
Angioedema is a relatively common clinical disorder. Although most cases are idiopathic, the use of angiotensin‐converting enzyme inhibitors is a well recognized cause of angioedema and a further rare but important diagnostic consideration is acquired C1 inhibitor deficiency. We discuss the diagnosis of C1 inhibitor deficiency in angioedema, with reference to a case in which the diagnosis was initially masked by the use of corticosteroids, which normalized the C1 inhibitor level.